Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 21-30 of 40 (Search time: 0.002 seconds).
previous
1
2
3
4
next
Item hits:
Preview
Issue Date
Title
Author(s)
2008
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Mullighan, C.
;
Miller, C.
;
Radtke, I.
;
Philips, L.
;
Dalton, J.
;
Ma, J.
;
White, D.
;
Hughes, T.
;
Le Beau, M.
;
Pui, C.
;
Relling, M.
;
Shurtleff, S.
;
Downing, J.
2001
Successful salvage of RAEB/AML relapsing early post allograft with FLAG-Ida conditioned mini-allograft: a report of two cases
Hui, C.
;
Bardy, P.
;
Hughes, T.
;
Horvath, N.
;
To, L.
2002
Dual transcription of b2a2 and b3a2 BCR-ABL transcripts in chronic myeloid leukaemia is confined to patients with a linked polymorphism within the BCR gene
Branford, S.
;
Hughes, T.
;
Rudzki, Z.
2009
Clinical strategies to achieve an early and successful response to tyrosine kinase inhibitor therapy
Hughes, T.
;
Hochhaus, A.
2003
Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR
Hui, C.
;
Goh, K.
;
White, D.
;
Branford, S.
;
Grigg, A.
;
Seymour, J.
;
Kwan, Y.
;
Walsh, S.
;
Hoyt, R.
;
Trickett, A.
;
Rudzki, Z.
;
Ma, D.
;
To, L.
;
Hughes, T.
2008
Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemia
Giles, F.
;
DeAngelo, D.
;
Baccarani, M.
;
Deininger, M.
;
Guilhot, F.
;
Hughes, T.
;
Radich, J.
;
Ottmann, O.
;
Cortes, J.
2004
Clinical resistance to imatinib: mechanisms and implications
Hochhaus, A.
;
Hughes, T.
2009
Impact of baseline BCR-ABL mutations on response to Nilotinib in patients with chronic myeloid leukemia in chronic phase
Hughes, T.
;
Saglio, G.
;
Branford, S.
;
Soverini, S.
;
Kim, J.
;
Muller, M.
;
Martinelli, G.
;
Cortes, J.
;
Beppu, L.
;
Gottardi, E.
;
Dongho, K.
;
Erben, P.
;
Shou, Y.
;
Haque, A.
;
Gallagher, N.
;
Radich, J.
;
Hochhaus, A.
2009
Selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure: does the BCR-ABL mutation status really matter?
Branford, S.
;
Vaz de Melo, J.
;
Hughes, T.
2009
Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations
Muller, M.
;
Cortes, J.
;
Kim, D.
;
Druker, B.
;
Erben, P.
;
Pasquini, R.
;
Branford, S.
;
Hughes, T.
;
Radich, J.
;
Ploughman, L.
;
Mukhopadhyay, J.
;
Hochhaus, A.
Discover
Author
13
Branford, S.
12
Hochhaus, A.
8
White, D.
6
Cortes, J.
6
Goldman, J.
6
Radich, J.
5
Grigg, A.
5
Rudzki, Z.
5
To, L.
4
Apperley, J.
.
next >
Subject
27
Leukemia, Myelogenous, Chronic, B...
25
Pyrimidines
24
Benzamides
24
Imatinib Mesylate
24
Piperazines
20
Fusion Proteins, bcr-abl
16
Male
14
Adult
14
Antineoplastic Agents
14
Female
.
next >
Date issued
8
2009
6
2008
2
2007
4
2006
3
2005
2
2004
7
2003
4
2002
1
2001
3
2000
.
next >